Group 1 - The company is a shareholder in Zhongborun Kang Medical and is responsible for the pharmaceutical research related to its BNCT drug BPA [1] - There is no collaboration between the company and TAE Life Sciences, a subsidiary of TAE Technologies in the United States [1]